韓国の高齢者のうつ病を減らすためのLIFE-Gプログラム
Jung-Min Han1, Kang-Hyun Park2, Hae Yean Park1
1Yonsei University, Wonju, South Korea.
OTJR : occupation, participation and health
|February 15, 2026
まとめ
"LIFE-G (Lifestyle Intervention For Everyone-Group) "プログラムでは,高齢者のうつ病を効果的に軽減しました. このライフスタイルの介入は,地域社会に住む高齢者の福祉に対する実現可能性と肯定的な影響を示しました.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 公衆衛生は公衆衛生である.
- 行動科学は,行動科学である.
背景:
- 鬱病は,コミュニティに住む高齢者の重要な懸念事項です.
- ライフスタイルの要因は,高齢者の精神的健康に重要な役割を果たします.
研究 の 目的:
- ライフスタイル・インターベンション・フォー・エヴリーブン・グループ (LIFE-G) プログラムの実現可能性を評価する.
- 高齢者のうつ病の軽減におけるLIFE-Gプログラムの有効性を評価する.
主な方法:
- 1グループプレテスト・ポストテストの設計が採用されました.
- 8セッションの4週間のライフスタイル介入が実施されました.
- ウィルコクソン署名ランクテストは,うつ病,ライフスタイル,自己効力度の変化を評価した.
主要な成果:
- 参加者は,うつ病の症状の有意な改善を示しました.
- 自己効能レベルは介入後増加した.
- 多面的なライフスタイルの側面は,ポジティブな変化を示しました.
結論:
- LIFE-Gプログラムは,コミュニティに住む高齢者のために実現可能であるようです.
- ライフスタイルの介入は,高齢者のうつ病の管理に有効である可能性があります.
- LIFE-Gプログラムは,高齢者の精神的健康を改善するための約束を示しています.
関連する概念動画
Long-term Depression
33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Long-term Depression
3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.4K
Depression: Overview
936
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
936
Alzheimer's Disease: Treatment
994
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
994
Aging
849
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
849
Antidepressant Drugs: Overview
1.6K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.6K


